{"id":"https://openalex.org/W3083320029","doi":"https://doi.org/10.17116/oftalma2020136042201","title":"Neurodegenerative biomarkers of the response to diabetic macular edema treatment","display_name":"Neurodegenerative biomarkers of the response to diabetic macular edema treatment","alternate_titles":[],"publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W3083320029","doi":"https://doi.org/10.17116/oftalma2020136042201","mag":"3083320029","pmid":"https://pubmed.ncbi.nlm.nih.gov/32880140"},"language":"ru","primary_location":{"id":"doi:10.17116/oftalma2020136042201","doi":"https://doi.org/10.17116/oftalma2020136042201","is_oa":false,"landing_page_url":"https://doi.org/10.17116/oftalma2020136042201","pdf_url":null,"source":{"id":"https://openalex.org/S2764585551","display_name":"Russian Annals of Ophthalmology","issn_l":"0042-465X","issn":["0042-465X","2309-1282"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["medline","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320238","host_organization_name":"Meditsina","host_organization_lineage":["https://openalex.org/P4310320238"],"host_organization_lineage_names":["Meditsina"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vestnik oftal'mologii","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3083320029"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029011182","display_name":"D.V. Petrachkov","orcid":"https://orcid.org/0000-0003-4757-5584","observed_orcids":["https://orcid.org/0000-0003-4757-5584"]},"institutions":[{"id":"https://openalex.org/I4210109183","display_name":"Helmholtz Moscow Research Institute of Eye Diseases","ror":"https://ror.org/01xkgje29","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210109183"]},{"id":"https://openalex.org/I4210133635","display_name":"Federal State Scientific Institution Research Institute of Eye Diseases","ror":"https://ror.org/0422tyr14","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210110862","https://openalex.org/I4210133635"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"D.V. Petrachkov","raw_affiliation_strings":["Research Institute of Eye Diseases, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute of Eye Diseases, Moscow, Russia","institution_ids":["https://openalex.org/I4210109183","https://openalex.org/I4210133635"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038780008","display_name":"Maria V. Budzinskaya","orcid":"https://orcid.org/0000-0002-5507-8775","observed_orcids":["https://orcid.org/0000-0002-5507-8775"]},"institutions":[{"id":"https://openalex.org/I4210109183","display_name":"Helmholtz Moscow Research Institute of Eye Diseases","ror":"https://ror.org/01xkgje29","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210109183"]},{"id":"https://openalex.org/I4210133635","display_name":"Federal State Scientific Institution Research Institute of Eye Diseases","ror":"https://ror.org/0422tyr14","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210110862","https://openalex.org/I4210133635"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"M.V. Budzinskaya","raw_affiliation_strings":["Research Institute of Eye Diseases, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute of Eye Diseases, Moscow, Russia","institution_ids":["https://openalex.org/I4210109183","https://openalex.org/I4210133635"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032555865","display_name":"Vladislav Pavlov","orcid":"https://orcid.org/0000-0001-6744-4907","observed_orcids":["https://orcid.org/0000-0001-6744-4907"]},"institutions":[{"id":"https://openalex.org/I4210109183","display_name":"Helmholtz Moscow Research Institute of Eye Diseases","ror":"https://ror.org/01xkgje29","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210109183"]},{"id":"https://openalex.org/I4210133635","display_name":"Federal State Scientific Institution Research Institute of Eye Diseases","ror":"https://ror.org/0422tyr14","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210110862","https://openalex.org/I4210133635"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"V.G. Pavlov","raw_affiliation_strings":["Research Institute of Eye Diseases, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute of Eye Diseases, Moscow, Russia","institution_ids":["https://openalex.org/I4210109183","https://openalex.org/I4210133635"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110607886","display_name":"M.H. Durzhinskaya","orcid":"https://orcid.org/0000-0002-3806-3985","observed_orcids":["https://orcid.org/0000-0002-3806-3985"]},"institutions":[{"id":"https://openalex.org/I4210109183","display_name":"Helmholtz Moscow Research Institute of Eye Diseases","ror":"https://ror.org/01xkgje29","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210109183"]},{"id":"https://openalex.org/I4210133635","display_name":"Federal State Scientific Institution Research Institute of Eye Diseases","ror":"https://ror.org/0422tyr14","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210110862","https://openalex.org/I4210133635"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"M.H. Durzhinskaya","raw_affiliation_strings":["Research Institute of Eye Diseases, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute of Eye Diseases, Moscow, Russia","institution_ids":["https://openalex.org/I4210109183","https://openalex.org/I4210133635"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067043318","display_name":"Anait S. Khalatyan","orcid":"https://orcid.org/0000-0001-6255-5544","observed_orcids":["https://orcid.org/0000-0001-6255-5544"]},"institutions":[{"id":"https://openalex.org/I4210109183","display_name":"Helmholtz Moscow Research Institute of Eye Diseases","ror":"https://ror.org/01xkgje29","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210109183"]},{"id":"https://openalex.org/I4210133635","display_name":"Federal State Scientific Institution Research Institute of Eye Diseases","ror":"https://ror.org/0422tyr14","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210110862","https://openalex.org/I4210133635"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A.S. Khalatyan","raw_affiliation_strings":["Research Institute of Eye Diseases, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute of Eye Diseases, Moscow, Russia","institution_ids":["https://openalex.org/I4210109183","https://openalex.org/I4210133635"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1725,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.7390465,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"136","issue":"4","first_page":"201","last_page":"201"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":1.0},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":0.9940000176429749},{"id":"https://openalex.org/keywords/neurodegeneration-markers","display_name":"neurodegeneration biomarkers","score":0.8960000276565552},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.9700000286102295},{"id":"https://openalex.org/keywords/retinal-nerve-fiber-layer-thickness","display_name":"retinal nerve fiber layer thickness","score":0.9710000157356262},{"id":"https://openalex.org/keywords/ganglion-cell-complex-thickness","display_name":"ganglion cell complex thickness","score":0.8299999833106995},{"id":"https://openalex.org/keywords/ellipsoid-zone-integrity","display_name":"ellipsoid zone integrity","score":0.9399999976158142},{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.796999990940094},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.8679999709129333},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9679999947547913},{"id":"https://openalex.org/keywords/central-retinal-thickness","display_name":"central retinal thickness","score":0.7960000038146973},{"id":"https://openalex.org/keywords/best-corrected-visual-acuity","display_name":"best-corrected visual acuity","score":0.8799999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8556334972381592},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.8272259831428528},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.7860445380210876},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.5870183706283569},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5647280216217041},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.5644265413284302},{"id":"https://openalex.org/C2778749236","wikidata":"https://www.wikidata.org/wiki/Q4689286","display_name":"Aflibercept","level":4,"score":0.5633242130279541},{"id":"https://openalex.org/C2777093970","wikidata":"https://www.wikidata.org/wiki/Q169342","display_name":"Retina","level":2,"score":0.535966157913208},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.5231577157974243},{"id":"https://openalex.org/C2780592520","wikidata":"https://www.wikidata.org/wiki/Q4423908","display_name":"Nerve fiber layer","level":3,"score":0.5047723054885864},{"id":"https://openalex.org/C2780188069","wikidata":"https://www.wikidata.org/wiki/Q4133186","display_name":"Ganglion cell layer","level":3,"score":0.4706028401851654},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.45695945620536804},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3367275595664978},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23304280638694763},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.13812434673309326},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.07009091973304749},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.06332242488861084},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012165","descriptor_name":"Retinal Ganglion Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D041623","descriptor_name":"Tomography, Optical Coherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.17116/oftalma2020136042201","doi":"https://doi.org/10.17116/oftalma2020136042201","is_oa":false,"landing_page_url":"https://doi.org/10.17116/oftalma2020136042201","pdf_url":null,"source":{"id":"https://openalex.org/S2764585551","display_name":"Russian Annals of Ophthalmology","issn_l":"0042-465X","issn":["0042-465X","2309-1282"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["medline","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320238","host_organization_name":"Meditsina","host_organization_lineage":["https://openalex.org/P4310320238"],"host_organization_lineage_names":["Meditsina"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vestnik oftal'mologii","raw_type":"journal-article"},{"id":"pmid:32880140","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32880140","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vestnik oftalmologii","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1782108791","https://openalex.org/W1982179488","https://openalex.org/W2033514298","https://openalex.org/W2125347938","https://openalex.org/W2801681779","https://openalex.org/W2884705338","https://openalex.org/W2980547569","https://openalex.org/W3016883261","https://openalex.org/W3025091949"],"related_works":["https://openalex.org/W4410996111","https://openalex.org/W4377138668","https://openalex.org/W7205011746","https://openalex.org/W3140310534","https://openalex.org/W4224675632","https://openalex.org/W7134065305","https://openalex.org/W4377042966","https://openalex.org/W7162118441","https://openalex.org/W7166536537","https://openalex.org/W3134304631"],"abstract_inverted_index":{"There":[0],"are":[1],"currently":[2],"no":[3],"reliable":[4],"biomarkers":[5,106,259],"for":[6],"predicting":[7],"the":[8,20,27,58,82,104,108,143,155,158,163,174,184,190,197,215,225,228,240,261,264,273,285],"response":[9,28,109,262],"to":[10,29,102,110,246,263],"treatment":[11,39,144],"of":[12,23,26,32,60,77,84,91,107,119,135,154,166,173,176,189,209,217,224,227,236,239,251,260,272,284],"diabetic":[13,218],"macula":[14],"edema":[15],"(DME).":[16],"PURPOSE:":[17],"To":[18],"asses":[19],"predictive":[21],"role":[22],"neurodegenerative":[24,105],"biomarker":[25],"anti-VEGF":[30,111,265],"therapy":[31,267],"DME.":[33,49,257],"MATERIAL":[34],"AND":[35],"METHODS:":[36],"Examination":[37],"and":[38,68,133,157,179,192,207,277],"was":[40,79,87,140],"carried":[41],"out":[42],"on":[43],"14":[44,69],"patients":[45,114,253],"(20":[46],"eyes)":[47],"with":[48,64,71,214,254],"The":[50,75,234],"eyes":[51,63,70],"were":[52,93],"divided":[53],"into":[54],"2":[55,73],"groups":[56],"by":[57],"type":[59,65,72,208],"diabetes:":[61],"6":[62],"1":[66],"diabetes":[67,78],"diabetes.":[74,210],"duration":[76],"16.5\u00b17.9":[80],"years,":[81],"level":[83],"glycated":[85],"hemoglobin":[86],"8.4\u00b12%.":[88],"A":[89],"number":[90],"indicators":[92],"evaluated":[94],"using":[95],"optical":[96],"coherence":[97],"tomography":[98],"(OCT)":[99],"in":[100,127,162,183,196],"order":[101],"determine":[103],"treatment.":[112,232],"All":[113],"underwent":[115],"standard":[116],"loading":[117],"course":[118,235],"Aflibercept":[120,241],"(5":[121],"intravitreal":[122,237],"injections).":[123],"RESULTS:":[124],"Significant":[125],"improvement":[126],"Best":[128],"Corrected":[129],"Visual":[130],"Acuity":[131],"(BCVA)":[132],"decrease":[134],"central":[136],"retinal":[137,167],"thickness":[138,165,172,188,271],"(CRT)":[139],"seen":[141],"after":[142],"course.":[145],"Data":[146],"analysis":[147],"revealed":[148],"a":[149],"correlation":[150],"between":[151],"functional":[152],"outcomes":[153,212],"treatment,":[156],"following":[159],"pathological":[160],"changes":[161],"retina:":[164],"nerve":[168],"fiber":[169],"layer":[170],"(RNFL),":[171],"complex":[175,194],"ganglion":[177],"cell":[178],"inner":[180],"plexiform":[181],"layers":[182],"macular":[185,198],"region":[186],"(GCL+),":[187],"RNFL":[191],"GCL+":[193,276],"(GCL++)":[195],"region,":[199],"\u0394CRT,":[200],"as":[201,203,280,282],"well":[202,281],"BCVA,":[204],"patient":[205],"age,":[206],"Anatomical":[211],"correlate":[213],"stage":[216],"retinopathy,":[219],"RNFL,":[220,275],"GCL+,":[221],"GCL++,":[222],"violation":[223],"integrity":[226,283],"ellipsoid":[229,286],"zone":[230],"before":[231],"CONCLUSION:":[233],"administration":[238],"drug":[242,266],"has":[243],"been":[244,269],"established":[245],"be":[247],"an":[248],"effective":[249],"method":[250],"treating":[252],"clinically":[255],"significant":[256],"Neurodegenerative":[258],"have":[268],"determined:":[270],"peripapillary":[274],"GCL":[278],"++,":[279],"zone.":[287]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3083320029","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2020-09-11T00:00:00"}
